BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 31899107)

  • 1. Diffusion-Weighted MR Imaging of Primary and Secondary Lung Cancer: Predictive Value for Response to Transpulmonary Chemoembolization and Transarterial Chemoperfusion.
    Vogl TJ; Hoppe AT; Gruber-Rouh T; Basten L; Dewes P; Hammerstingl RM; Balaban Ü; Mastrodicasa D; Thompson ZM; Albrecht MH
    J Vasc Interv Radiol; 2020 Feb; 31(2):301-310. PubMed ID: 31899107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting Treatment Response of Colorectal Cancer Liver Metastases to Conventional Lipiodol-Based Transarterial Chemoembolization Using Diffusion-Weighted MR Imaging: Value of Pretreatment Apparent Diffusion Coefficients (ADC) and ADC Changes Under Therapy.
    Lahrsow M; Albrecht MH; Bickford MW; Vogl TJ
    Cardiovasc Intervent Radiol; 2017 Jun; 40(6):852-859. PubMed ID: 28357571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosed chest lesion on diffusion-weighted magnetic resonance images using apparent diffusion coefficients.
    Lu NH; Hung CM; Liu KY; Chen TB; Huang YH
    J Xray Sci Technol; 2016; 24(1):133-43. PubMed ID: 26890904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of treatment response of chemoembolization in hepatocellular carcinoma with diffusion-weighted imaging on 3.0-T MR imaging.
    Sahin H; Harman M; Cinar C; Bozkaya H; Parildar M; Elmas N
    J Vasc Interv Radiol; 2012 Feb; 23(2):241-7. PubMed ID: 22019180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Water mobility of diffusion MRI in prediction of response to chemoembolization in liver cancer].
    Yuan Z; Ye XD; Dong S; Xu LC; Sun ZC; Xiao XS
    Zhonghua Zhong Liu Za Zhi; 2009 Apr; 31(4):293-7. PubMed ID: 19615287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
    Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
    Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility of assessing pulmonary blood volume using C-arm CT during transpulmonary chemoperfusion and chemoembolization in primary and secondary lung tumours.
    Vogl TJ; Nour-Eldin NE; Naguib NN; Lehnert T; Ackermann H; Hammerstingl R; Hezel M
    Br J Radiol; 2016 Jun; 89(1062):20150244. PubMed ID: 27046514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immediate post-doxorubicin drug-eluting beads chemoembolization Mr Apparent diffusion coefficient quantification predicts response in unresectable hepatocellular carcinoma: A pilot study.
    Kokabi N; Camacho JC; Xing M; Edalat F; Mittal PK; Kim HS
    J Magn Reson Imaging; 2015 Oct; 42(4):981-9. PubMed ID: 25683022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of early response to chemotherapy in lung cancer by using diffusion-weighted MR imaging.
    Yu J; Li W; Zhang Z; Yu T; Li D
    ScientificWorldJournal; 2014; 2014():135841. PubMed ID: 24688359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of magnetic resonance diffusion-weighted imaging in evaluating response after chemoembolization of hepatocellular carcinoma.
    Yuan Z; Ye XD; Dong S; Xu LC; Xu XY; Liu SY; Xiao XS
    Eur J Radiol; 2010 Jul; 75(1):e9-14. PubMed ID: 19540083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline and Early MR Apparent Diffusion Coefficient Quantification as a Predictor of Response of Unresectable Hepatocellular Carcinoma to Doxorubicin Drug-Eluting Bead Chemoembolization.
    Kokabi N; Ludwig JM; Camacho JC; Xing M; Mittal PK; Kim HS
    J Vasc Interv Radiol; 2015 Dec; 26(12):1777-86. PubMed ID: 26603497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting liver metastasis of gastrointestinal tract cancer by diffusion-weighted imaging of apparent diffusion coefficient values.
    Zheng DX; Meng SC; Liu QJ; Li CT; Shang XD; Zhu YS; Bai TJ; Xu SM
    World J Gastroenterol; 2016 Mar; 22(10):3031-7. PubMed ID: 26973399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of metastatic breast cancer response to chemoembolization with contrast agent enhanced and diffusion-weighted MR imaging.
    Buijs M; Kamel IR; Vossen JA; Georgiades CS; Hong K; Geschwind JF
    J Vasc Interv Radiol; 2007 Aug; 18(8):957-63. PubMed ID: 17675611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
    Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
    Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of pretreatment diffusion-weighted magnetic resonance imaging for outcome prediction of colorectal cancer liver metastases undergoing 90Y-microsphere radioembolization.
    Schmeel FC; Simon B; Luetkens JA; Träber F; Meyer C; Schmeel LC; Sabet A; Ezziddin S; Schild HH; Hadizadeh DR
    J Cancer Res Clin Oncol; 2017 Aug; 143(8):1531-1541. PubMed ID: 28317063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transvenous pulmonary chemoembolization (TPCE) for palliative or neoadjuvant treatment of lung metastases.
    Vogl TJ; Mekkawy AIA; Thabet DB; El-Sharkaway M; Kamel HM; Albrecht MH; Naguib NNN; Hassan A
    Eur Radiol; 2019 Apr; 29(4):1939-1949. PubMed ID: 30338364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiating between malignant and benign solid solitary pulmonary lesions: are intravoxel incoherent motion and diffusion kurtosis imaging superior to conventional diffusion-weighted imaging?
    Wan Q; Deng YS; Lei Q; Bao YY; Wang YZ; Zhou JX; Zou Q; Li XC
    Eur Radiol; 2019 Mar; 29(3):1607-1615. PubMed ID: 30255258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Islet cell liver metastases: assessment of volumetric early response with functional MR imaging after transarterial chemoembolization.
    Li Z; Bonekamp S; Halappa VG; Corona-Villalobos CP; Pawlik T; Bhagat N; Reyes D; Lai H; Geschwind JF; Kamel IR
    Radiology; 2012 Jul; 264(1):97-109. PubMed ID: 22627602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transarterial chemoembolization in pancreatic adenocarcinoma with liver metastases: MR-based tumor response evaluation, apparent diffusion coefficient (ADC) patterns, and survival rates.
    Vogl TJ; Mohamed SA; Albrecht MH; Gruber-Roh T; Lin H; Nour Eldin NEA; Bednarova I; Naguib NN; Panahi B
    Pancreatology; 2018 Jan; 18(1):94-99. PubMed ID: 29221632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver metastases from colorectal cancer treated with conventional and antiangiogenetic chemotherapy: evaluation with liver computed tomography perfusion and magnetic resonance diffusion-weighted imaging.
    Anzidei M; Napoli A; Zaccagna F; Cartocci G; Saba L; Menichini G; Cavallo Marincola B; Marotta E; Di Mare L; Catalano C; Passariello R
    J Comput Assist Tomogr; 2011; 35(6):690-6. PubMed ID: 22082538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.